In the last trading session, 2.57 million shares of the OptiNose Inc (NASDAQ:OPTN) were traded, and its beta was -0.14. Most recently the company’s share price was $0.38, and it changed around -$0.06 or -11.49% from the last close, which brings the market valuation of the company to $55.52M. OPTN currently trades at a discount to its 52-week high of $2.10, offering almost -452.63% off that amount. The share price’s 52-week low was $0.41, which indicates that the current value has fallen by an impressive -7.89% since then. We note from OptiNose Inc’s average daily trading volume that its 10-day average is 1.12 million shares, with the 3-month average coming to 461.39K.
OptiNose Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended OPTN as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. OptiNose Inc is expected to report earnings per share of -0.05 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
OptiNose Inc (NASDAQ:OPTN) trade information
Instantly OPTN has showed a red trend with a performance of -11.49% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.6900 on recent trading dayincreased the stock’s daily price by 44.93%. The company’s shares are currently down -70.16% year-to-date, but still down -49.88% over the last five days. On the other hand, OptiNose Inc (NASDAQ:OPTN) is -51.88% down in the 30-day period. We can see from the shorts that 8.57 million shares have been sold at a short interest cover period of 34.65 day(s).
The consensus price target as assigned by Wall Street analysts is $3, which translates to bulls needing to increase their stock price by 87.33% from its current value. Analyst projections state that OPTN is forecast to be at a low of $1 and a high of $5.
OptiNose Inc (OPTN) estimates and forecasts
OptiNose Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -67.92 percent over the past six months and at a 37.50% annual growth rate that is well above the industry average of 15.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 48.14% in revenue this quarter, and will report an increase of 58.33% in the next quarter. The year-over-year growth rate is expected to be 11.19%, up from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 22.31M in revenue for the current quarter. 1 analysts expect OptiNose Inc to make 17.7M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 19.86M and 14.88M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 12.29%. Forecasts for the next quarter put sales growth at 18.95%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 34.78%.
OPTN Dividends
OptiNose Inc’s next quarterly earnings report is expected to be released in December.
OptiNose Inc (NASDAQ:OPTN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 5.98% of OptiNose Inc shares, and 76.83% of them are in the hands of institutional investors. The stock currently has a share float of 81.71%. OptiNose Inc stock is held by 79.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 14.2309% of the shares, which is about 16.02 million shares worth $16.66 million.
MVM PARTNERS, LLC, with 12.9715% or 14.61 million shares worth $15.04 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
